In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: An update from the pediatric AIDS clinical trials group 219 and 219C cohorts [4]

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 535-536

  Brogly, Susan ^a   Williams, Paige ^a   Seage III, George R ^b   Van Dyke, Russell ^c  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

CANCER INCIDENCE; CARCINOGENICITY; CHILD; CHILDHOOD CANCER; CUTANEOUS T CELL LYMPHOMA; DRUG EXPOSURE; GENOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LETTER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; REVERSE TRANSCRIPTASE INHIBITORS; STATISTICS;

EID: 33646797733     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000194735.66322.d9     Document Type: Letter

References (5)

1. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. February 24, 2005. Available at: http://aidsinfo.nih.gov/ guidelines.
2. Poirier M, Olivero O, Walker D, et al. Perinatal genotoxicity and carcinogenicity of antiretroviral nucleoside analog drugs. Toxicol Appl Pharmacol. 2004;199:151-161.
3. Hanson C, Antonelli T, Sperling R, et al. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr. 1999;20: 463-467.
4. Ries L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review 1975-2001. Bethesda: National Cancer Institute; 2004. Available at: http://seer.cancer.gov/csr/1975-2001.
5. Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol. 2005;78:232-239.